Skip to content
foodoseGet my numbers
TrialsApril 23, 20263 min read

Weight Regain After Stopping Ozempic: A 1-Hour 'Gut Reset'

An investigational 1-hour endoscopic 'gut reset' (DMR) blunted weight regain after stopping Ozempic-class drugs in the REMAIN-1 trial. Promising, early, still investigational.

For many women, the hardest question on a GLP-1 is not how to lose, but how to keep what they have. Weight regain after stopping Ozempic, Wegovy, Mounjaro, or Zepbound is the rule, not the exception, because the body defends its old set point once the medication leaves. So a new trial presented at Digestive Disease Week in April 2026 is worth a careful look: a 1-hour endoscopic procedure, nicknamed a "gut reset," that may soften the rebound.

What happened

The procedure is called duodenal mucosal resurfacing, or DMR. Using a slim catheter passed through the mouth (no incisions), a doctor delivers controlled heat to a thin layer of the small intestine's lining so that fresher tissue can grow back. The idea is to reset how the gut senses food and signals the rest of the body.

In the REMAIN-1 trial, led by Dr. Shelby Sullivan at Dartmouth Health Weight Center and sponsored by Fractyl Health, 45 adults (80% of them women, median age 43) first lost at least 15% of their body weight on tirzepatide, the drug sold as Mounjaro and Zepbound. They then stopped the medication. Twenty-nine received DMR; sixteen got a sham (placebo) procedure so neither group knew which they had.

Three months after stopping the drug, the DMR group kept losing, dropping a further 2.5% of body weight, while the sham group regained 10%. At the six-month read, those who had more tissue resurfaced held on to more than 80% of their loss and regained roughly seven pounds; the sham group put back about double that, a regain around 40% larger.

What this means for you

Two cautions matter more than the headline. First, this is early and investigational. DMR is not approved by the FDA for weight maintenance, and the pivotal six-month data from the full program of more than 300 people is not expected until late in 2026. Second, the trial used tirzepatide specifically, so the same numbers should not be assumed for semaglutide (Ozempic, Wegovy).

What the trial quietly confirms is the thing you already feel: stopping a GLP-1 is a physiological event, not a willpower test. If a one-hour procedure can move the regain curve, the rebound was never about discipline. That should take some weight off your shoulders, whatever happens with the device.

The proven basics have not changed. Protein at every meal and strength training to protect the muscle you worked to keep do the unglamorous work of holding your new weight. A planned, gradual step-down with your prescriber beats a sudden stop. And the metabolic set point that drives regain is exactly what DMR is trying to nudge, which is why the basics that defend muscle still matter most.

What to do with this

Whatever comes after the medication, the eating problem is the same one: enough protein, enough fibre, enough fluid. The calculator gives you those three numbers with the arithmetic attached.

Get your numbers

People also ask
What is the gut reset procedure for weight regain?
It is called duodenal mucosal resurfacing, or DMR. A doctor passes a slim catheter through the mouth, with no incisions, and delivers controlled heat to a thin layer of the small intestine's lining so that fresher tissue grows back. The aim is to reset how the gut senses food and signals the rest of the body. It takes about an hour.
Does the gut reset stop weight regain after stopping a GLP-1?
It blunted it in one early trial. In REMAIN-1, presented at Digestive Disease Week in April 2026, led by Dr Shelby Sullivan at Dartmouth Health Weight Center and sponsored by Fractyl Health, 45 adults, 80% of them women with a median age of 43, first lost at least 15% of their body weight on tirzepatide and then stopped the medication. Twenty nine received DMR and sixteen a sham procedure, so neither group knew which they had.
Can I get the gut reset procedure?
No. It is investigational, and the evidence so far is a single early trial in 45 people. Weight regain after stopping a GLP-1 is the rule rather than the exception, because the body defends its old set point once the medication leaves, so a procedure that softens that rebound is worth watching. Watching is the right verb for now.
Read the originalScienceDaily (REMAIN-1, Digestive Disease Week)Open

From the recipe collection

Recipes that fit

Each with a stated portion and its nutrition calculated from the ingredients.

Go deeper

The news changes weekly. What protects your body doesn't.

Work yours out once: your calorie target, your protein floor, and three days of food built to them. Free, and no sign-up.

More from the Brief